Baynes Roy D.

Travere Therapeutics, Inc. · Director

Baynes Roy D. is listed in public filings as director. This Baynes Roy D. insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Travere Therapeutics, Inc. (TVTX), Nurix Therapeutics, Inc. (NRIX), and Natera Inc (NTRA). Investors use Baynes Roy D.'s insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

Latest Actions

Company	Holding Value	Last Transaction	Amount	Transaction Price	Current Price
Travere Therapeutics, Inc.TVTX	$507k12k shares	Grant / ExerciseMay 19, 2026	$507.1K12k shares	$42.26	--
Travere Therapeutics, Inc.TVTX	--41.5k shares	Grant / ExerciseMay 19, 2026	Disclosure amount unavailable4k shares	--	--

Insider Trades History

Company	Holding Value	Last Transaction	Amount	Transaction Price	Current Price
Nurix Therapeutics, Inc.NRIX	$496k31.3k shares	Grant / ExerciseMay 15, 2026	$495.6K31.3k shares	$15.86	--
Travere Therapeutics, Inc.TVTX	$1.7M37.5k shares	SellMay 5, 2026	$209.9K4.5k shares	$46.65	--
Travere Therapeutics, Inc.TVTX	$04.5k shares	Grant / ExerciseMay 5, 2026	$82.2K4.5k shares	$18.27	--
Travere Therapeutics, Inc.TVTX	$1.7M37.5k shares	SellMay 1, 2026	$431.1K9.8k shares	$44.22	--
Travere Therapeutics, Inc.TVTX	$66k9.8k shares	Grant / ExerciseMay 1, 2026	$66.5K9.8k shares	$6.82	--
Natera IncNTRA	--18.5k shares	Grant / ExerciseApr 24, 2026	Disclosure amount unavailable83 shares	--	--
Travere Therapeutics, Inc.TVTX	$1.8M44.3k shares	SellApr 14, 2026	$1.1M26k shares	$41.07	--
Travere Therapeutics, Inc.TVTX	$1.6M37.5k shares	SellApr 14, 2026	$284.3K6.8k shares	$42.12	--
Travere Therapeutics, Inc.TVTX	$08k shares	Grant / ExerciseApr 14, 2026	$143.5K8k shares	$17.94	--
Travere Therapeutics, Inc.TVTX	$09k shares	Grant / ExerciseApr 14, 2026	$138.9K9k shares	$15.43	--
Travere Therapeutics, Inc.TVTX	$115k6.8k shares	Grant / ExerciseApr 14, 2026	$115.5K6.8k shares	$17.11	--
Travere Therapeutics, Inc.TVTX	$96k4.5k shares	Grant / ExerciseApr 14, 2026	$96.2K4.5k shares	$21.38	--
Travere Therapeutics, Inc.TVTX	$82k4.5k shares	Grant / ExerciseApr 14, 2026	$82.2K4.5k shares	$18.27	--
Travere Therapeutics, Inc.TVTX	$1.2M37.5k shares	SellApr 6, 2026	$330.0K10k shares	$33.00	--
Travere Therapeutics, Inc.TVTX	$010k shares	Grant / ExerciseApr 6, 2026	$265.2K10k shares	$26.52	--
Natera IncNTRA	--18.4k shares	Grant / ExerciseJan 30, 2026	Disclosure amount unavailable70 shares	--	--
Nurix Therapeutics, Inc.NRIX	$238k25k shares	Grant / ExerciseMay 19, 2025	$237.8K25k shares	$9.51	--
Travere Therapeutics, Inc.TVTX	$412k19.5k shares	Grant / ExerciseMay 15, 2025	$412.4K19.5k shares	$21.15	--
Travere Therapeutics, Inc.TVTX	--37.5k shares	Grant / ExerciseMay 15, 2025	Disclosure amount unavailable6.5k shares	--	--
Nurix Therapeutics, Inc.NRIX	$695k50k shares	Grant / ExerciseMar 11, 2025	$695.0K50k shares	$13.90	--
Travere Therapeutics, Inc.TVTX	$682k31k shares	SellFeb 6, 2025	$220.0K10k shares	$22.00	--
Travere Therapeutics, Inc.TVTX	$010k shares	Grant / ExerciseFeb 6, 2025	$174.4K10k shares	$17.44	--